Malignant melanoma: perspectives on incidence and its effects on awareness, diagnosis, and treatment.

PubWeight™: 0.86^‹?›

🔗 View Article (PMID 8673692)

Published in CA Cancer J Clin on August 09, 1996

Authors

Author Affiliations

1: Department of Dermatology, New York University School of Medicine, New York, USA.

Associated clinical trials:

Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles | NCT00005781

Articles citing this ↘

Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study. J Clin Pathol (2006) 1.24

A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire. Mol Med (1998) 1.04

Dermoscopic and clinical features of trunk melanomas. Postepy Dermatol Alergol (2014) 0.94

Role of the G Protein-Coupled Receptor, mGlu1, in Melanoma Development. Pharmaceuticals (Basel) (2010) 0.76

Articles by these authors ⇆

Malignant melanoma: incidence issues and their effect on diagnosis and treatment in the 1990s. Mayo Clin Proc (1997) 1.02